α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system

Journal of Neural Transmission

Volumn 119, Issue 7, 2012, Pages 739-746

  Mollenhauer, Brit ^a,b   Trautmann, Ellen ^a   Otte, Birgit ^a   Ng, Juliana ^c   Spreer, Annette ^b   Lange, Peter ^b   Sixel Döring, Friederike ^a   Hakimi, Mansoureh ^c   VonSattel, Jean Paul ^d   Nussbaum, Robert ^e   Trenkwalder, Claudia ^a,b   Schlossmacher, Michael G ^c  

^a PARACELSUS ELENA KLINIK   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Synuclein; Biomarker; Blood CSF barrier; Cerebrospinal fluid; Choroid plexus

Indexed keywords

ALBUMIN; ALPHA SYNUCLEIN; ENOLASE;

ADULT; AGED; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHOROID PLEXUS; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN CONTENT;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BIOLOGICAL MARKERS; BRAIN; CHOROID PLEXUS; FEMALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MIDDLE AGED; NEURONS; PHOSPHOPYRUVATE HYDRATASE;

EID: 84863425120     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0784-0     Document Type: Article

References (29)

1. Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C (1993) Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 33:129-133
2. Chodobski A, Szmydynger-Chodobska J (2001) Choroid plexus: target for polypeptides and site of their synthesis. Microsc Res Tech 52:65-82
3. Crossgrove JS, Li GJ, Zheng W (2005) The Choroid Plexus Removes {beta}-Amyloid from Brain Cerebrospinal Fluid. Exp Biol Med 230:771-776
4. Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynela J (2009) Cathepsin D expression level affects α-Synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2:5
5. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-Synuclein. Proc Natl Acad Sci USA 106:13010-13015
6. Emmanouilidou E, Elenis D, Papasilekas T, Stranjalis G, Gerozissis K, Ioannou PC, Vekrellis K (2011) Assessment of alphasynuclein secretion in mouse and human brain parenchyma. PLoS ONE 6:e22225
7. Grouper S, Walker MT, Parrish TB, McCarthy RJ, Wong CA (2006) Lumbosacral cerebrospinal fluid volume in humans using threedimensional magnetic resonance imaging. Anesth Analg 103: 1306-1310
8. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic. Press. Hedges LV&Vevea JL Academic Press, Orlando
9. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and α-Synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133: 713-726
10. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic α-Synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405-1410
11. Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL (2011) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-Synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19:1633-1650
12. Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of α-Synuclein and its aggregates. J Neurosci 25:6016-6024
13. Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB (2005) Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 62:1004-1007
14. Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, Ng J, Schulz-Schaeffer W, Kretzschmar HA, McLean PJ, Trenkwalder C, Sarracino DA, Vonsattel JP, Locascio JJ, El-Agnaf OM, Schlossmacher MG (2008) Direct quantification of CSF α-Synuclein by ELISA and first crosssectional study in patients with neurodegeneration. Exp Neurol 213:315-325
15. MollenhauerB, El-AgnafOM,MarcusK, TrenkwalderC, Schlossmacher MG (2010) Quantification of α-Synuclein in cerebrospinal fluid as a biomarker candidate: reviewof the literature and considerations for future studies. Biomark Med 4:683-699
16. Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) alphα-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230-240
17. Page EB (1963) Ordered hypothesis for multiple treatments: A significance test for linear ranks. J Am Stat Assoc 58(301): 216-230. doi:10.2307/2282965
18. Ray JW, Shadish WR (1996) How interchangeable are different estimators of effect size? J Consult Clin Psychol 64:1316-1325
19. Reiber H (2001) Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310:173-186
20. Reiber H (2003) Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21:79-96
21. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM (2005) Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57:S4-S16 (discussion ii-v)
22. Schaarschmidt H, Prange HW, Reiber H (1994) Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 25:558-565
23. Scherzer CR, Grass JA, Liao Z, Pepivani I, Zheng B, Eklund AC, Ney PA, Ng J, McGoldrick M, Mollenhauer B, Bresnick EH, Schlossmacher MG (2008) GATA transcription factors directly regulate the Parkinson's disease-linked gene α-Synuclein. Proc Natl Acad Sci USA 105:10907-10912
24. Schlossmacher MG, Frosch MP, Gai WP, Medina M, Sharma N, Forno L, Ochiishi T, Shimura H, Sharon R, Hattori N, Langston JW, Mizuno Y, Hyman BT, Selkoe DJ, Kosik KS (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 160:1655-1667
25. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) α-Synuclein locus triplication causes Parkinson's disease. Science 302:841
26. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synucleinin Lewy bodies. Nature 388:839-840
27. Tumani H, Nau R, Felgenhauer K (1998) Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44:882-889
28. Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous α-Synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57-71
29. Wolburg H, Paulus W (2010) Choroid plexus: biology and pathology. Acta Neuropathol 119:75-88